| Filed On | Filing |
|---|---|
| 25 Jun 2026 |
Form 3: Cox Troy, Director
No securities owned |
| 25 Jun 2026 |
Form 3: Babler Martin, Director
No securities owned |
| 27 Oct 2025 | Form 3: Catalyst4, Inc., 10% owner |
| 27 Oct 2025 | Form 3: Novo Holdings A/S, 10% owner |
| 27 Oct 2025 |
Form 3: Trenkle James D., Director
No securities owned |
| 27 Oct 2025 |
Form 3: Pavlov George, Chief Medical Officer
No securities owned |
| 27 Oct 2025 |
Form 3: Luneborg Nanna Liebach, Director
No securities owned |
| 27 Oct 2025 |
Form 3: Hanson Kristopher, General Counsel
Holds 182,761 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Kreitzer Anatol, Chief Discovery Officer
Holds 260,054 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Foff Erin Pennock, Chief Medical Officer
Holds 386,816 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Garnett Timothy John, Director
Holds 43,231 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Lillie James Woodruff, Chief Scientific Officer
Holds 303,648 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Setia Vishwas, Chief Financial Officer
Holds 377,834 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Gillis Jonathan, CAAO and PAO
Holds 239,988 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Walker Maria C, Director
Holds 52,477 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Kroeger Christopher A., Director
Holds 1,601,164 shares of Voting Common Stock |
| 27 Oct 2025 |
Form 3: Malenka Robert C., Director
Holds 365,281 shares of Voting Common Stock |
Loading...
